KURA ONCOLOGY INC. - COMMON STOCK

Kura Oncology to Participate in Upcoming Investor Conferences

01 3 2023 06:30:00 提供 Nasdaq GlobeNewswire

Kura Oncology Reports Fourth Quarter and Full Year 2022 Financial Results

23 2 2023 15:03:00 提供 Nasdaq GlobeNewswire

Kura Oncology to Report Fourth Quarter and Full Year 2022 Financial Results

16 2 2023 06:30:00 提供 Nasdaq GlobeNewswire

Kura Oncology Announces First Patients Dosed in Phase 2 Registration-Directed Trial of Ziftomenib in NPM1-Mutant Acute Myeloid Leukemia

09 2 2023 06:30:00 提供 Nasdaq GlobeNewswire

Kura Oncology to Participate in SVB Securities Global Biopharma Conference

07 2 2023 06:30:00 提供 Nasdaq GlobeNewswire

Kura Oncology Announces FDA Clearance of IND Application for KO-2806, a Next-Generation Farnesyl Transferase Inhibitor

24 1 2023 06:30:00 提供 Nasdaq GlobeNewswire

Kura Oncology Presents Updated Clinical Data from KOMET-001 Trial of Menin Inhibitor Ziftomenib at American Society of Hematology Annual Meeting

10 12 2022 09:30:00 提供 Nasdaq GlobeNewswire

Kura Oncology to Host Investor Event on December 10, 2022

01 12 2022 06:30:00 提供 Nasdaq GlobeNewswire

Kura Oncology to Participate in Two Upcoming Investor Conferences

22 11 2022 06:30:00 提供 Nasdaq GlobeNewswire

Kura Oncology Announces Four Abstracts Accepted for Presentation at ASH Annual Meeting

03 11 2022 08:01:13 提供 Nasdaq GlobeNewswire

Kura Oncology Reports Third Quarter 2022 Financial Results

03 11 2022 06:30:01 提供 Nasdaq GlobeNewswire

Kura Oncology Announces Financing Transactions with Bristol Myers Squibb and Hercules Capital, Providing Access to up to $150 Million

03 11 2022 06:00:01 提供 Nasdaq GlobeNewswire

Kura Oncology to Participate in Two Upcoming Investor Conferences

02 11 2022 06:30:00 提供 Nasdaq GlobeNewswire

Kura Oncology to Report Third Quarter 2022 Financial Results  

27 10 2022 06:30:00 提供 Nasdaq GlobeNewswire

Kura Oncology Reports Preliminary Proof of Mechanism in Phase 1/2 Clinical Trial of Tipifarnib Plus Alpelisib in Head and Neck Squamous Cell Carcinoma

26 10 2022 06:30:01 提供 Nasdaq GlobeNewswire

Kura Oncology to Participate in H.C. Wainwright Global Investment Conference

01 9 2022 06:30:00 提供 Nasdaq GlobeNewswire

Kura Oncology Reports Second Quarter 2022 Financial Results

03 8 2022 15:03:00 提供 Nasdaq GlobeNewswire

Kura Oncology to Participate in Wedbush PacGrow Healthcare Virtual Conference

02 8 2022 06:30:00 提供 Nasdaq GlobeNewswire

Kura Oncology to Report Second Quarter 2022 Financial Results

27 7 2022 06:30:00 提供 Nasdaq GlobeNewswire

Kura Oncology to Participate in Three Upcoming Investor Conferences

26 5 2022 06:30:00 提供 Nasdaq GlobeNewswire